Orphan Drug ProductionRare DiseasesDrug ApprovalUnited States Food and Drug AdministrationLegislation, DrugEconomics, PharmaceuticalDrug IndustryTropical MedicineEthics, PharmacyOff-Label UsePatents as TopicEuropean UnionDrug CostsMarketingInsurance, Health, ReimbursementPharmacologyCost ControlUnited StatesEuropeInsurance, Pharmaceutical ServicesChild, Orphaned